| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/28/2009 | CA2706534A1 Improved cytokine design |
| 05/28/2009 | CA2706506A1 Plants having increased yield-related traits and a method for making the same |
| 05/28/2009 | CA2706439A1 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
| 05/28/2009 | CA2705871A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/28/2009 | CA2705603A1 Variants of c-type natriuretic peptide |
| 05/28/2009 | CA2703903A1 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 05/27/2009 | EP2063272A1 Porcine intrinsic factor |
| 05/27/2009 | EP2062976A2 Site specific incorporation of keto amino acids into proteins |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062913A1 Toxoplasma GONDII antigens, P35, and uses thereof |
| 05/27/2009 | EP2062590A1 Peptide derived from Hepatitis C virus |
| 05/27/2009 | EP2062589A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 05/27/2009 | EP2062246A2 Chimeric virus vaccines |
| 05/27/2009 | EP2061887A1 Vlp based vaccine delivery system |
| 05/27/2009 | EP2061886A1 Small cationic antimicrobial peptides |
| 05/27/2009 | EP2061885A1 Stroma derived predictor of breast cancer |
| 05/27/2009 | EP2061884A2 Sensor proteins and assay methods |
| 05/27/2009 | EP2061882A2 Glucoamylase variants with altered properties |
| 05/27/2009 | EP2061879A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 05/27/2009 | EP2061807A2 Mhc oligomers, components thereof, and methods of making the same |
| 05/27/2009 | EP2061806A2 Gainac specific binding molecules and uses thereof |
| 05/27/2009 | EP2061805A1 Recombinant hcv e2 glycoprotein |
| 05/27/2009 | EP2061511A2 Smallpox monoclonal antibody |
| 05/27/2009 | EP2061507A2 Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1 |
| 05/27/2009 | EP2061502A2 Carbohydrate-based vaccines for hlv |
| 05/27/2009 | EP2061499A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 05/27/2009 | EP2061498A2 Compositions and methods to prevent cancer with cupredoxins |
| 05/27/2009 | EP2061495A2 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 05/27/2009 | EP2061492A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 05/27/2009 | EP2061488A2 Selectively targeted antimicrobial peptides and the use thereof |
| 05/27/2009 | EP1877563A4 Plants containing a heterologous flavohemoglobin gene and methods of use thereof |
| 05/27/2009 | EP1753454B1 Vaccine for periodontal disease |
| 05/27/2009 | EP1740173A4 Azabicyclo-octane inhibitors of iap |
| 05/27/2009 | EP1664284B1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof |
| 05/27/2009 | EP1651666B1 Alphavirus-based cytomegalovirus vaccines |
| 05/27/2009 | EP1644028B1 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 05/27/2009 | EP1567189B1 Malaria vaccine |
| 05/27/2009 | EP1558643B1 T cell receptor display |
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
| 05/27/2009 | EP1544298B1 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 05/27/2009 | EP1525219B1 Glp-1 and methods for treating diabetes |
| 05/27/2009 | EP1403365B1 Polypeptide unstabilizing protein in cells under aerobic conditions and dna encoding the same |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1343880B1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic bovine |
| 05/27/2009 | EP1337554B1 Novel compounds |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1235915B1 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP1161562B1 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines |
| 05/27/2009 | EP1132402B1 Peptide fragments having cell death inhibitory activity |
| 05/27/2009 | EP1003850B1 Inhibitors of dna immunostimulatory sequence activity |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | EP0832228B1 Modified hemoglobin-like compounds and methods of purifying same |
| 05/27/2009 | CN101443454A Polysaccharide-protein latticeing substance and vaccine derivatized from polyvalent meningitis cocci |
| 05/27/2009 | CN101443358A Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| 05/27/2009 | CN101443357A MCP1 fusions |
| 05/27/2009 | CN101443356A Neuromedin U receptor agonists and uses thereof |
| 05/27/2009 | CN101443355A Active potassium channel transporters (akt) and their use tocreate stress tolerant plants |
| 05/27/2009 | CN101443354A Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
| 05/27/2009 | CN101443353A Regulation of activity of glutamine synthetase |
| 05/27/2009 | CN101443035A Vaccine for treatment or prophylaxis therapy of myasthenia gravis |
| 05/27/2009 | CN101443029A Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 05/27/2009 | CN101443022A Use of a growth-stimulating protein |
| 05/27/2009 | CN101440370A Preparation of allophycocyanin fluorescent protein |
| 05/27/2009 | CN101440369A Expression method of deleted zonula occludens toxin gene of Vibrio cholerae and use |
| 05/27/2009 | CN101440368A Chinese cabbage dewatered response transcription factor BpDREB-2 gene sequence |
| 05/27/2009 | CN101440367A Chinese cabbage dewatered response transcription factor BpDREB-1 gene sequence |
| 05/27/2009 | CN101440129A Anti-HIV-1 outer membrane jogged protein monoclonal antibody |
| 05/27/2009 | CN101440128A Differentially expressed protein in human glioma and uses thereof |
| 05/27/2009 | CN101439185A Method for preparing composite preparation for treating lung cancer |
| 05/27/2009 | CN100491534C cDNA sequence of salt algae 26S proteasome subunit RPN10 gene, its coding protein and full-length gene sequence and clone method |
| 05/27/2009 | CN100491531C Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 05/27/2009 | CN100491530C Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/27/2009 | CN100491529C HrpN gene for encoding plant multifunction activity and broad spectrum resistance cell signal factor and its expression product and use |
| 05/27/2009 | CN100491527C Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 05/27/2009 | CN100491521C Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 05/27/2009 | CN100491396C Selective cyclic peptides |
| 05/27/2009 | CN100491395C Process for producing modified peptide |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/26/2009 | US7538260 Antisense oligonucleotides for use in controlling flowering in crops |
| 05/26/2009 | US7538258 Transgenic nonhuman animal having germ or somatic cell containing nucleic acid encoding human amyloid precursor protein including nucleotides encoding codon 670 and 671; diagnosing and/or predicting predisposition; drug screening |
| 05/26/2009 | US7538209 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/26/2009 | US7538208 Expression vector comprising nucleotide sequences coding portion of ADP-ribosylating toxin for use treatment and prevention of gramnegative bacterial infection |
| 05/26/2009 | US7538207 Polyepitope carrier protein |
| 05/26/2009 | US7538206 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 05/26/2009 | US7538205 Regulation of human prostasin-like serine protease |
| 05/26/2009 | US7538203 Expression vector comprising nucleotide sequences coding legumin-like proteins for use as tool in diagnosing and treating nut allergies |
| 05/26/2009 | US7538201 Viral particle comprising nucleotide sequences coding gB gene of infectious laryngotracheitis virus for use in generation of vaccine to prevent respiratory system disorders |
| 05/26/2009 | US7538198 Methods for protein refolding |
| 05/26/2009 | US7538197 Use of neuregulin-β as an indicator and/or target |
| 05/26/2009 | US7538193 Using deoxy-S-nitrosohemoglobin and glutathione, cysteine and/or N-acetylcysteine to treat and prevent ischemic injury, hypertension, angina, reperfusion injury and inflammation |
| 05/26/2009 | US7538192 Nucleotide sequence/polypeptide fusion for use as capture tool on solid supports during genomic analysis |
| 05/26/2009 | US7538191 Kinetochore protein Sgo1 (shugoshin) for use as tool in identifying agents which control protein degradation during anaphase (meiotic) |
| 05/26/2009 | US7538187 Coloring compositions with peptide-based dispersants and binders |
| 05/26/2009 | US7538185 Treating a disease or condition associated with a disorder of glucose metabolism; diabetes mellitus of Type I or Type II, insulin resistance |
| 05/26/2009 | US7538183 HPV vaccine comprising peptides from host cell proteins |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7538088 Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide |
| 05/26/2009 | US7538087 Agent against periodontal disease |